Valiant Organics Share Price
Sector: Chemical Manufacturing
336.80 -16.30 (-4.62%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
326.30
Today’s High
355.85
52 Week Low
225.00
52 Week High
455.20
329.65 -22.35 (-6.35%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
325.00
Today’s High
358.80
52 Week Low
227.05
52 Week High
456.20
Key Metrics
- Market Cap (In Cr) 923.03
- Beta 0.94
- Div. Yield (%) 0
- P/B 1.25
- TTM P/E -
- Sector P/E 19.07
- Open Price 353.15
- Prev Close 353.1
Valiant Organics Analysis
Price Analysis
-
1 Week-3.02%
-
3 Months6.6%
-
6 Month-17.07%
-
YTD7.61%
-
1 Year-20.76%
Risk Meter
- 52% Low risk
- 52% Moderate risk
- 52% Balanced Risk
- 52% High risk
- 52% Extreme risk
Valiant Organics News
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy
1 min read . 09 Apr 2025These three beaten-down stocks are prime candidates for a turnaround
5 min read . 23 Oct 2024Buy or sell: Vaishali Parekh recommends three stocks to buy today — August 27
2 min read . 27 Aug 2024Valiant Organics Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 723.06
- Selling/ General/ Admin Expenses Total
- 145.68
- Depreciation/ Amortization
- 34.92
- Other Operating Expenses Total
- 9.98
- Total Operating Expense
- 723.07
- Operating Income
- -0.01
- Net Income Before Taxes
- -8.14
- Net Income
- -7.83
- Diluted Normalized EPS
- -2.14
- Period
- 2024
- Total Assets
- 1247.96
- Total Liabilities
- 518.67
- Total Equity
- 729.29
- Tangible Book Valueper Share Common Eq
- 259.92
- Period
- 2024
- Cashfrom Operating Activities
- 83.84
- Cashfrom Investing Activities
- -64.99
- Cashfrom Financing Activities
- -4.06
- Net Changein Cash
- -4.27
- Period
- 2023
- Total Revenue
- 1051.8
- Selling/ General/ Admin Expenses Total
- 152.8
- Depreciation/ Amortization
- 29.19
- Other Operating Expenses Total
- 10.46
- Total Operating Expense
- 911.58
- Operating Income
- 140.22
- Net Income Before Taxes
- 137.18
- Net Income
- 88.12
- Diluted Normalized EPS
- 30.18
- Period
- 2023
- Total Assets
- 1239.23
- Total Liabilities
- 550.05
- Total Equity
- 689.18
- Tangible Book Valueper Share Common Eq
- 249.19
- Period
- 2023
- Cashfrom Operating Activities
- 237.93
- Cashfrom Investing Activities
- -142.74
- Cashfrom Financing Activities
- -112.48
- Net Changein Cash
- -17.3
- Period
- 2022
- Total Revenue
- 1153.27
- Selling/ General/ Admin Expenses Total
- 138.92
- Depreciation/ Amortization
- 29.62
- Other Operating Expenses Total
- 5.07
- Total Operating Expense
- 977.12
- Operating Income
- 176.15
- Net Income Before Taxes
- 176.17
- Net Income
- 113.28
- Diluted Normalized EPS
- 40.5
- Period
- 2022
- Total Assets
- 1184.75
- Total Liabilities
- 571.6
- Total Equity
- 613.15
- Tangible Book Valueper Share Common Eq
- 221.27
- Period
- 2022
- Cashfrom Operating Activities
- -32.47
- Cashfrom Investing Activities
- -122.23
- Cashfrom Financing Activities
- 166.91
- Net Changein Cash
- 12.21
- Period
- 2021
- Total Revenue
- 754.81
- Selling/ General/ Admin Expenses Total
- 107.72
- Depreciation/ Amortization
- 18.42
- Other Operating Expenses Total
- -1.85
- Total Operating Expense
- 568.48
- Operating Income
- 186.32
- Net Income Before Taxes
- 184.86
- Net Income
- 114.56
- Diluted Normalized EPS
- 41.68
- Period
- 2021
- Total Assets
- 875.85
- Total Liabilities
- 373.58
- Total Equity
- 502.27
- Tangible Book Valueper Share Common Eq
- 180.43
- Period
- 2021
- Cashfrom Operating Activities
- 115.1
- Cashfrom Investing Activities
- -158.59
- Cashfrom Financing Activities
- 48.67
- Net Changein Cash
- 5.18
- Period
- 2020
- Total Revenue
- 674.93
- Selling/ General/ Admin Expenses Total
- 80.63
- Depreciation/ Amortization
- 12.01
- Other Operating Expenses Total
- -1.81
- Total Operating Expense
- 508.54
- Operating Income
- 166.39
- Net Income Before Taxes
- 168.49
- Net Income
- 123.93
- Diluted Normalized EPS
- 45.32
- Period
- 2020
- Total Assets
- 669.1
- Total Liabilities
- 281.54
- Total Equity
- 387.57
- Tangible Book Valueper Share Common Eq
- 158.33
- Period
- 2020
- Cashfrom Operating Activities
- 161.26
- Cashfrom Investing Activities
- -183.62
- Cashfrom Financing Activities
- 27.16
- Net Changein Cash
- 4.8
- Period
- 2019
- Total Revenue
- 692.3
- Selling/ General/ Admin Expenses Total
- 32.48
- Depreciation/ Amortization
- 13.64
- Other Operating Expenses Total
- -1.8
- Total Operating Expense
- 523.14
- Operating Income
- 169.17
- Net Income Before Taxes
- 171.21
- Net Income
- 133.24
- Diluted Normalized EPS
- 43.66
- Period
- 2019
- Total Assets
- 481.09
- Total Liabilities
- 191.32
- Total Equity
- 289.77
- Tangible Book Valueper Share Common Eq
- 241.43
- Period
- 2019
- Cashfrom Operating Activities
- 84.09
- Cashfrom Investing Activities
- -94.01
- Cashfrom Financing Activities
- 1.01
- Net Changein Cash
- -8.92
- Period
- 2018
- Total Revenue
- 120.64
- Selling/ General/ Admin Expenses Total
- 4.78
- Depreciation/ Amortization
- 2.19
- Other Operating Expenses Total
- 15.1
- Total Operating Expense
- 96.43
- Operating Income
- 24.22
- Net Income Before Taxes
- 25.23
- Net Income
- 16.34
- Diluted Normalized EPS
- 13.93
- Period
- 2018
- Total Assets
- 96.27
- Total Liabilities
- 37.1
- Total Equity
- 59.18
- Tangible Book Valueper Share Common Eq
- 50.46
- Period
- 2018
- Cashfrom Operating Activities
- 17.77
- Cashfrom Investing Activities
- -6.23
- Cashfrom Financing Activities
- -5.02
- Net Changein Cash
- 6.52
- Period
- 2024-12-31
- Total Revenue
- 186.86
- Selling/ General/ Admin Expenses Total
- 12.11
- Depreciation/ Amortization
- 8.99
- Other Operating Expenses Total
- 40
- Total Operating Expense
- 180.52
- Operating Income
- 6.34
- Net Income Before Taxes
- 6.36
- Net Income
- 5.46
- Diluted Normalized EPS
- 2
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 160.18
- Selling/ General/ Admin Expenses Total
- 11.35
- Depreciation/ Amortization
- 8.79
- Other Operating Expenses Total
- 42.89
- Total Operating Expense
- 166.61
- Operating Income
- -6.43
- Net Income Before Taxes
- -13.77
- Net Income
- -12.78
- Diluted Normalized EPS
- -4.52
- Period
- 2024-09-30
- Total Assets
- 1173.44
- Total Liabilities
- 457.16
- Total Equity
- 716.28
- Tangible Book Valueper Share Common Eq
- 255.07
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 82.06
- Cashfrom Investing Activities
- -9.26
- Cashfrom Financing Activities
- -67.62
- Net Changein Cash
- 5.19
- Period
- 2024-06-30
- Total Revenue
- 167.92
- Selling/ General/ Admin Expenses Total
- 10.77
- Depreciation/ Amortization
- 8.78
- Other Operating Expenses Total
- 39.73
- Total Operating Expense
- 160.99
- Operating Income
- 6.93
- Net Income Before Taxes
- 2.23
- Net Income
- -0.62
- Diluted Normalized EPS
- -0.23
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 176.76
- Selling/ General/ Admin Expenses Total
- 12.37
- Depreciation/ Amortization
- 8.77
- Other Operating Expenses Total
- 37.06
- Total Operating Expense
- 199.56
- Operating Income
- -22.81
- Net Income Before Taxes
- -25.13
- Net Income
- -17.22
- Diluted Normalized EPS
- -4.08
- Period
- 2024-03-31
- Total Assets
- 1247.96
- Total Liabilities
- 518.67
- Total Equity
- 729.29
- Tangible Book Valueper Share Common Eq
- 259.92
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 83.84
- Cashfrom Investing Activities
- -64.99
- Cashfrom Financing Activities
- -4.06
- Net Changein Cash
- -4.27
- Period
- 2023-12-31
- Total Revenue
- 141.36
- Selling/ General/ Admin Expenses Total
- 12.34
- Depreciation/ Amortization
- 8.6
- Other Operating Expenses Total
- 33.9
- Total Operating Expense
- 146.18
- Operating Income
- -4.82
- Net Income Before Taxes
- -9.81
- Net Income
- -7.89
- Diluted Normalized EPS
- -2.9
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 203.1
- Selling/ General/ Admin Expenses Total
- 13.25
- Depreciation/ Amortization
- 8.89
- Other Operating Expenses Total
- 39.6
- Total Operating Expense
- 196.5
- Operating Income
- 6.6
- Net Income Before Taxes
- 6.41
- Net Income
- 4.3
- Diluted Normalized EPS
- 1.54
- Period
- 2023-09-30
- Total Assets
- 1252.61
- Total Liabilities
- 546.6
- Total Equity
- 706.01
- Tangible Book Valueper Share Common Eq
- 255.25
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 66.21
- Cashfrom Investing Activities
- -35.52
- Cashfrom Financing Activities
- -27.17
- Net Changein Cash
- -5.2
- Period
- 2023-06-30
- Total Revenue
- 201.84
- Selling/ General/ Admin Expenses Total
- 11.39
- Depreciation/ Amortization
- 8.67
- Other Operating Expenses Total
- 36.32
- Total Operating Expense
- 180.9
- Operating Income
- 20.94
- Net Income Before Taxes
- 19.84
- Net Income
- 12.42
- Diluted Normalized EPS
- 2.89
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 271.4
- Selling/ General/ Admin Expenses Total
- 12.47
- Depreciation/ Amortization
- 7.98
- Other Operating Expenses Total
- 42.4
- Total Operating Expense
- 227.37
- Operating Income
- 44.03
- Net Income Before Taxes
- 44.1
- Net Income
- 29.76
- Diluted Normalized EPS
- 10.64
- Period
- 2023-03-31
- Total Assets
- 1239.23
- Total Liabilities
- 550.05
- Total Equity
- 689.18
- Tangible Book Valueper Share Common Eq
- 249.19
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 237.93
- Cashfrom Investing Activities
- -142.74
- Cashfrom Financing Activities
- -112.48
- Net Changein Cash
- -17.3
- Period
- 2022-12-31
- Total Revenue
- 250.37
- Selling/ General/ Admin Expenses Total
- 12.54
- Depreciation/ Amortization
- 7.27
- Other Operating Expenses Total
- 38.31
- Total Operating Expense
- 214.53
- Operating Income
- 35.83
- Net Income Before Taxes
- 34.69
- Net Income
- 21.97
- Diluted Normalized EPS
- 6.53
- Period
- 2022-12-31
- Period
- 2022-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Valiant Organics Technical
Moving Average
SMA
- 5 Day355.16
- 10 Day355.98
- 20 Day330.45
- 50 Day290.88
- 100 Day302.43
- 300 Day351.3
Valiant Organics Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Tuticorin Alkali Chem And Fertil
- 79.21
- -1.01
- -1.26
- 112
- 68
- 962.75
- Indo Amines
- 131.4
- -6
- -4.37
- 247.9
- 95
- 932.85
- Valiant Organics
- 336.8
- -16.3
- -4.62
- 455.2
- 225
- 923.03
- Shivalik Rasayan
- 593.85
- -20.25
- -3.3
- 873.6
- 500.5
- 910.36
- Zuari Agro Chemicals
- 218
- -16.7
- -7.12
- 268
- 151
- 922.12
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Tuticorin Alkali Chem And Fertil
- 13.28
- 12.16
- -
- 4.49
- Indo Amines
- 22.77
- 3.56
- 17.26
- 4.25
- Valiant Organics
- -
- 1.25
- 15.99
- 11.01
- Shivalik Rasayan
- 70.04
- 2.18
- 7.08
- 11.66
- Zuari Agro Chemicals
- 36.22
- 0.54
- 10.37
- 3.52
Valiant Organics Shareholding
Shareholding Pattern
*Promoter pledging: 0%
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 13-Feb-25
- Quarterly Results
- 13-Nov-24
- Quarterly Results
- 13-Aug-24
- Quarterly Results
- 24-May-24
- Audited Results
- 13-Feb-24
- Quarterly Results
- 08-Nov-23
- Quarterly Results
- 09-Aug-23
- Quarterly Results
- 19-May-23
- Audited Results
- 31-Jan-23
- Quarterly Results & Interim Dividend
- 08-Nov-22
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 03-Jan-25
- 02-Dec-24
- POM
- 21-Aug-24
- 31-Jul-24
- AGM
- 16-Apr-24
- 14-Mar-24
- POM
- 15-Sept-23
- 19-May-23
- AGM
- 13-Jul-23
- 09-Jun-23
- POM
- 28-Sept-22
- 04-Aug-22
- AGM
- 17-Jun-22
- 13-May-22
- POM
- 29-Sept-21
- 14-Aug-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 31-Jan-23
- 10-Feb-23
- 10-Feb-23
- 1
- 25-May-22
- 21-Sept-22
- 20-Sept-22
- 3.5


